Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,005 public trials 1,217 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Not Yet Recruiting

Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma

NCT05502991

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Henan Provincial People's Hospital Zhengzhou, Henan, China

View Trial Details

Not Yet Recruiting

Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable Melanoma

NCT05539118

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Air Force Military Medical University/ Fourth Military Medical University Xi'an, Shaanxi, China

View Trial Details

Not Yet Recruiting

Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma

NCT05303727

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Establishing Radiolabelled PSMA as a Target for Glioma Treatment

NCT05263466

Conditions: Glioma, Glioma, Malignant, Neoplasms, +6 more
Locations: King's College London London, United Kingdom

View Trial Details

Not Yet Recruiting

ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab

NCT05366062

Conditions: Glioma, Glioma, Malignant, Neoplasms, +6 more
Locations: Bumrungrad International Hospital Bangkok, Vadhana, Thailand

View Trial Details

Not Yet Recruiting

Mapping Molecular Markers of Brain Tumour Activity Using MRI

NCT05140785

Conditions: Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: King's R&I department London, United Kingdom

View Trial Details

Not Yet Recruiting

Study of CD160, an Activating NK Cell Receptor, in Melanoma: a Potential Therapeutic Target?

NCT04477876

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Cytokine-induced Killer Study for Patients With Stage II Melanoma

NCT02498756

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Completed

NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors

NCT01875601

Conditions: Brain Diseases, Brain Neoplasms, Brain Tumors, +19 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III

NCT02761070

Conditions: Astrocytoma, Disease Attributes, Disease Progression, +13 more
Locations: Nagoya University Hospital Nagoya, Aichi-ken, Japan

Fujita Health University Hospital Toyoake, Aichi-ken, Japan

Hirosaki University School of Medicine Hirosaki, Aomori, Japan

Chiba University Hospital Chiba, Japan

View all 37 locations

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions